Familiar fixes for a modern malady: a discussion on the possible cures of COVID-19

Familiar fixes for a modern malady: a discussion on the possible cures of COVID-19

The SARS-CoV-2 virus emerged in December 2019 in Wuhan, China and then spread rapidly all over the world. Scientists are intensifying their research efforts in order to find antivirals specific to the virus and vaccines to treat or prevent COVID-19. Now, for a medicative cure for COVID-19, several d...

Detaylı Bibliyografya
Yazar:	Amrit Krishna Mitra
Materyal Türü:	Makale
Dil:	English
Baskı/Yayın Bilgisi:	AIMS Press 2020-12-01
Seri Bilgileri:	AIMS Molecular Science
Konular:	covid-19 sars-cov-2 chloroquine hydroxychloroquine lopinavir ritonavir remdesivir favipiravir vitamin c convalescent plasma
Online Erişim:	http://www.aimspress.com/article/10.3934/molsci.2020012?viewType=HTML

Benzer Materyaller

Review of Clinical Trials in COVID-19: Trying to Solve the Clinicians’ Conundrum
Yazar:: Amita Athavale, ve diğerleri
Baskı/Yayın Bilgisi: (2020-07-01)

COVID-19: An Update about the Discovery Clinical Trial
Yazar:: Jean Jacques Vanden Eynde
Baskı/Yayın Bilgisi: (2020-05-01)

Therapeutic Strategies in the Management of COVID-19
Yazar:: Rajashri R. Naik, ve diğerleri
Baskı/Yayın Bilgisi: (2021-02-01)

A narrative review of antiviral drugs used for COVID-19 pharmacotherapy
Yazar:: Subodh Kumar, ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01)

COVID-19: A Brief Overview of the Discovery Clinical Trial
Yazar:: Jean Jacques Vanden Eynde
Baskı/Yayın Bilgisi: (2020-04-01)

A Comparative Study of Approved Drugs for SARS-CoV-2 by Molecular Docking
Yazar:: Achal Mishra, ve diğerleri
Baskı/Yayın Bilgisi: (2021-06-01)

COVID-19 possible medical treatments
Yazar:: Marzieh Mohammadi, ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01)

Current Clinical Trials and Vaccine Development Strategies for Corona Virus Disease (COVID-19)
Yazar:: Abhi Bhadra, ve diğerleri
Baskı/Yayın Bilgisi: (2020-05-01)

Clinical efficacy of antivirals against novel coronavirus (COVID-19): A review
Yazar:: Shahamah Jomah, ve diğerleri
Baskı/Yayın Bilgisi: (2020-09-01)

Biological, molecular and pharmacological characteristics of chloroquine, hydroxychloroquine, convalescent plasma, and remdesivir for COVID-19 pandemic: A comparative analysis
Yazar:: Sultan Ayoub Meo, ve diğerleri
Baskı/Yayın Bilgisi: (2020-10-01)

Comparison of effectiveness of various treatment strategies in COVID-19 patients: A Systematic Review
Yazar:: Muhammad Shehryar Hussain, ve diğerleri
Baskı/Yayın Bilgisi: (2020-08-01)

Pharmacological management of COVID-19
Yazar:: Veena Raghunathan, ve diğerleri
Baskı/Yayın Bilgisi: (2020-01-01)

An early assessment of the efficacy of medicines in the treatment of patients with COVID-19
Yazar:: A. S. Kolbin
Baskı/Yayın Bilgisi: (2020-05-01)

Safety of Hydroxychloroquine, Favipiravir, and the Combination of Lopinavir and Ritonavir in the Treatment of the “First Wave” of the New Coronavirus Infection COVID-19
Yazar:: B. K. Romanov
Baskı/Yayın Bilgisi: (2020-09-01)

Role of adjunctive treatment strategies in COVID-19 and a review of international and national clinical guidelines
Yazar:: Xinni Xu, ve diğerleri
Baskı/Yayın Bilgisi: (2020-05-01)

The Rationale for Potential Pharmacotherapy of COVID-19
Yazar:: Maha Saber-Ayad, ve diğerleri
Baskı/Yayın Bilgisi: (2020-05-01)

Effectiveness of Remdesivir, Lopinavir/Ritonavir, and Favipiravir for COVID-19 Treatment: A Systematic Review
Yazar:: Qomara WF, ve diğerleri
Baskı/Yayın Bilgisi: (2021-11-01)

Drug Repurposing in the COVID-19 Era: Insights from Case Studies Showing Pharmaceutical Peculiarities
Yazar:: Milo Gatti, ve diğerleri
Baskı/Yayın Bilgisi: (2021-02-01)

Characteristics and outcomes of acute respiratory distress syndrome related to COVID-19 in Belgian and French intensive care units according to antiviral strategies: the COVADIS multicentre observational study
Yazar:: David Grimaldi, ve diğerleri
Baskı/Yayın Bilgisi: (2020-10-01)

COVID-19 treatment in children: A systematic review and meta-analysis
Yazar:: Prateek Kumar Panda, ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01)

Repurposed pharmacological agents for the potential treatment of COVID-19: a literature review
Yazar:: Alina Kröker, ve diğerleri
Baskı/Yayın Bilgisi: (2021-11-01)

Pharmacogenomics landscape of COVID-19 therapy response in Serbian population and comparison with worldwide populations
Yazar:: Stanković Biljana, ve diğerleri
Baskı/Yayın Bilgisi: (2020-01-01)

Severe coronavirus disease 2019 (COVID‐19) pneumonia patients treated successfully with a combination of lopinavir/ritonavir plus favipiravir: Case series
Yazar:: Hayato Koba, ve diğerleri
Baskı/Yayın Bilgisi: (2020-12-01)

Systematic Review on the Therapeutic Options for COVID-19: Clinical Evidence of Drug Efficacy and Implications
Yazar:: Abubakar AR, ve diğerleri
Baskı/Yayın Bilgisi: (2020-12-01)

Clinical evaluation of selected Pharmacological Treatments used for Coronavirus (COVID-19) pandemic
Yazar:: hasan mohammed altemimy
Baskı/Yayın Bilgisi: (2020-06-01)

Efficacy of lopinavir/ritonavir plus interferon beta compared to hydroxychloroquine in the treatment of COVID-19: A retrospective observational study
Yazar:: Motahareh Amirizadeh, ve diğerleri
Baskı/Yayın Bilgisi: (2023-01-01)

High Prevalence of Potential Drug-Drug Interactions Among Patients Treated with Off-label Therapies for COVID-19
Yazar:: Allan Ramos-Esquivel, ve diğerleri
Baskı/Yayın Bilgisi: (2022-06-01)

Common anti-COVID-19 drugs and their anticipated interaction with anesthetic agents
Yazar:: Shagun B Shah, ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01)

Progress in the Research and Development of Anti-COVID-19 Drugs
Yazar:: Lianzhou Huang, ve diğerleri
Baskı/Yayın Bilgisi: (2020-07-01)

A multi-centre, randomized, double-blind, placebo-controlled clinical trial of the efficacy and safety of chloroquine phosphate, hydroxychloroquine sulphate and lopinavir/ritonavir for the treatment of COVID-19 in Lagos State: study protocol for a randomized controlled trial
Yazar:: A. Abayomi, ve diğerleri
Baskı/Yayın Bilgisi: (2021-12-01)

Measuring the energy for the molecular graphs of antiviral agents: Hydroxychloroquine, Chloroquine and Remdesivir
Yazar:: Muhammad Haroon Aftab, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

Evaluation of the efficacy and safety of favipiravir and interferon compared to lopinavir/ritonavir and interferon in moderately ill patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial
Yazar:: Mehdi Hassaniazad, ve diğerleri
Baskı/Yayın Bilgisi: (2020-10-01)

Pharmacophore modelling of vanillin derivatives, favipiravir, chloroquine, hydroxychloroquine, monolaurin and tetrodotoxin as MPro inhibitors of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
Yazar:: Woon Yi Law, ve diğerleri
Baskı/Yayın Bilgisi: (2020-11-01)

The Effectiveness of Hydroxychloroquine Versus Hydroxychloroquine Plus Lopinavir/Ritonavir Therapy in SARSCoV- 2 Pneumonia
Yazar:: Ayşe BATIREL, ve diğerleri
Baskı/Yayın Bilgisi: (2021-12-01)

Comparison of antiviral effect for mild-to-moderate COVID-19 cases between lopinavir/ritonavir versus hydroxychloroquine: A nationwide propensity score-matched cohort study
Yazar:: Min Joo Choi, ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01)

The Australasian COVID-19 Trial (ASCOT) to assess clinical outcomes in hospitalised patients with SARS-CoV-2 infection (COVID-19) treated with lopinavir/ritonavir and/or hydroxychloroquine compared to standard of care: A structured summary of a study protocol for a randomised controlled trial
Yazar:: Justin T. Denholm, ve diğerleri
Baskı/Yayın Bilgisi: (2020-07-01)

Antiviral activity of interferon-based combination therapy in critically ill patients with COVID-19: Preliminary observations
Yazar:: Paolo Gaibani, ve diğerleri
Baskı/Yayın Bilgisi: (2021-03-01)

Cardiotoxic Drugs Used in the Treatment of COVID-19
Yazar:: A. S. Zmitrukevich, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

Determination of lopinavir/ritonavir concentrations in four different oral solutions for the application of antiretroviral therapy in very young, HIV-1-infected children
Yazar:: Nils von Hentig, ve diğerleri
Baskı/Yayın Bilgisi: (2021-05-01)

Scoping insight on antiviral drugs against COVID-19
Yazar:: Ahmed S. Ali, ve diğerleri
Baskı/Yayın Bilgisi: (2021-10-01)